東湖高新(600133.SH)子公司中標高速公路網滬西至丘北至廣南至富寧高速公路工程PPP項目
格隆匯10月16日丨東湖高新(600133.SH)公佈,近日,公司全資子公司湖北省路橋集團有限公司(以下簡稱“湖北路橋”)收到文山州交通運輸局、天行健國際招標(北京)有限公司的《中標結果公告》,中標雲南省高速公路網滬西至丘北至廣南至富寧高速公路工程(文山州承建段)PPP項目。
項目合作期限共 34 年。項目經雲南省發展和改革委員會批覆的可研報告估算約為440.97億元。項目資本金為總投資的30.11%,即132.76億元,其中政府方出資48.12億元、社會資本方出資84.64億元。湖北路橋所涉及項目估算金額預計9.40億元,佔社會資本方出資比例的11.1111%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.